Physician profile
Randall Hicks
NPI 1982600060
$852.20
in general payments reported to CMS, 2019-2025
14 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $145 · 2021: $18.06 · 2022: $234 · 2023: $201 · 2024: $46.78 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.88 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $236.40 | 2020-2023 | Acthar |
| Aurinia Pharma U.S., INC. | $124.26 | 2022 | |
| Nxstage Medical, INC. | $111.91 | 2023 | Nxstage System One |
| Bayer Healthcare Pharmaceuticals INC. | $101.16 | 2025 | |
| Vifor Pharma, INC. | $52.93 | 2019-2020 | |
| Akebia Therapeutics INC | $46.78 | 2024 | Vafseo, Auryxia |
| Glaxosmithkline, LLC. | $43.90 | 2022-2023 | Benlysta |
| Novo Nordisk INC | $30.73 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $23.63 | 2019 | |
| Daiichi Sankyo INC. | $23.07 | 2020 | |
| Amarin Pharma, INC. | $15.36 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.15 | 2019 | |
| Assertio Therapeutics, INC. | $13.46 | 2020 | |
| Hikma Pharmaceuticals USA | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.